News

Examine Current and Possible Opportunities within the Transdermal Skin Patches Markets

DUBLIN, Ireland-(Business Wire)-October 3, 2008 - Research and Markets (http://www.researchandmarkets.com/research/29914c/transdermal_skin_p) has announced the addition of the "Transdermal Skin Patches - Markets and Opportunities" report to their offering.

Advances in synthetic materials and skin patch designs have led to transdermal drug delivery products that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Transdermal drug delivery patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Growth is being driven by several factors – factors with strong demographic and population trend underpinnings. New technologies are expanding the type and number of prescription and OTC therapies and treatments that can be effectively administered to patients and consumers. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Fueled by Rx-to-OTC switching, over-the-counter patches are proliferating as companies move to capture a share of this multi-billion dollar market. Non-medicated patches are creating new and significant markets for skin patches. The report is structured to provide transdermal drug delivery sector participants with all of the information necessary to identify marketing factors and business opportunities for transdermal drug delivery products.

Skin Patch Market Dynamics:

Created as an alternate route of administration to improve patient compliance and reduce prescription drug side effects, skin patches are rapidly becoming an important consumer healthcare product category. Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package.

Patches relying on passive transport mechanisms have been limited in their ability to deliver new classes of drugs, but formulations employing penetration enhancers, and patch designs incorporating microporation and energy-assisted delivery are expanding the range of drugs that can be effectively delivered transdermally. Growth in demand for drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2010.

Market Data

The study presents qualitative and quantitative data and information on key market measures and benchmarks:

- Market Size by Segment

- Market Share Data

- Patch Manufacturing

- Transdermal Technology

- Industry Structure

- Patch Economics

- Patch Design Criteria

- Product Pricing

- Emerging Markets

- Market Projections